Document is current
Any future updates will be listed below
-
Authors
Whipp, Alyce M. https://orcid.org/0000-0001-8376-8645
Korhonen, Tellervo https://orcid.org/0000-0003-2838-3085
Raevuori, Anu https://orcid.org/0000-0001-7704-9441
Heikkilä, Kauko https://orcid.org/0000-0002-9256-8028
Pulkkinen, Lea https://orcid.org/0000-0002-4290-6690
Rose, Richard J.
Kaprio, Jaakko https://orcid.org/0000-0002-3716-2455
Vuoksimaa, Eero https://orcid.org/0000-0002-6534-3667
-
Funding
Funding for this research was provided by:
European Union Seventh Framework Programme (602768)
National Institute of Alcohol Abuse and Alcoholism (AA-12502)
National Institute of Alcohol Abuse and Alcoholism (AA-00145)
National Institute of Alcohol Abuse and Alcoholism (AA-09203)
Academy of Finland (100499)
Academy of Finland (263278)
Academy of Finland (205585)
Academy of Finland (118555)
Academy of Finland (141054)
Academy of Finland (264146)
Academy of Finland (265240)
- License Information
-
More Information
Article History
Received: 5 February 2018
Accepted: 7 July 2018
First Online: 17 July 2018
Compliance with ethical standards
:
: J Kaprio and T Korhonen have consulted for Pfizer on nicotine dependence (2011–2015 and 2011–2017, respectively). AM Whipp, A Raevuori, K Heikkilä, L Pulkkinen, RJ Rose, and E Vuoksimaa declare no conflicts of interest.
